Applied StemCell (ASC) is a genome engineering platform company advancing the future of genetic and cell-based medicine through its proprietary TARGATT™ and S-SELeCT™ technologies. These innovations enable safe, scalable, site-specific integration of large payloads with reliable gene expression for the development of next-generation therapies, ex vivo and in vivo. With deep expertise in iPSCs and cell line engineering, ASC provides end-to-end solutions that accelerate innovation across academia and biopharma. Our strong IP foundation and cutting-edge technologies empower partners to move from concept to clinic with precision, scalability, and confidence. appliedstemcell.com
Looking for a particular Applied StemCell employee's phone or email?
The Applied StemCell annual revenue was $66.4 million in 2026.
Ruby Tsai is the President and Founder of Applied StemCell.
23 people are employed at Applied StemCell.
Applied StemCell is based in Milpitas, California.
The NAICS codes for Applied StemCell are [54138, 54, 5413, 541].
The SIC codes for Applied StemCell are [8734, 873, 87].